Explore 3 Stock Ideas & Industry Insights Download Free Report

News

T1 Energy (NYSE:TE) Narrows 2026 Module Production Guidance and Signs New 2027 Contracts

The company is building an integrated U.S.Supplychain for solar modules and cells. It manufactures and sells photovoltaic modules, along with battery energy storage systems and software solutions, and sells mainly into the utility-scale market.

Nitish Kishor | 13 November 2026

Tecogen (NYSE American:TGEN) Posts Higher Third-Quarter Revenue on Chiller and Services Gains

Product revenue was USD 3.05 million, up 2.2%. Chiller sales rose to USD 2.56 million from USD 2.23 million, which offset lower cogeneration sales of USD 492,890 and no engineered accessories revenue, compared with USD 234,000 a year earlier. The company noted that its …

Nitish Kishor | 13 November 2026

Talphera (NASDAQ:TLPH) Reports Third-Quarter Net Loss of USD 4.0 Million and Seeks FDA Meeting on Niyad Study Timing

The filing states that net loss was USD 4.0 million and USD 10.9 million for the three and nine months ended September 30, 2026, against USD 4.4 million and USD 10.5 million for the same periods of 2025.

Nitish Kishor | 13 November 2026

TMC the metals company (NASDAQ:TMC) Reports Third-Quarter Net Loss of USD 28.4 Million and Liquidity of USD 123 Million

Management said it is preparing to move from exploration into commercial operations, and noted that Liam Mallon, a former head of ExxonMobil's worldwideUpstreambusiness, joined its board in September and chairs its Sustainability and Innovation Committee.

Nitish Kishor | 13 November 2026

Tenon Medical (NASDAQ:TNON) Reports Third-Quarter Revenue of USD 1.4 Million, Up 22%, and Repays Convertible Notes in Full

President and Chief Executive Officer Steven M. Foster said revenue grew 22% year over year and 12% sequentially while operating expenses declined against both the third quarter of 2025 and the second quarter of 2026.

Nitish Kishor | 13 November 2026

Theriva Biologics (NYSE American:TOVX) Reports Lower Research Spending and USD 8.5 Million in Cash

The filing describes the enzyme as intended to break down the tumor stroma barrier surrounding the tumor. VCN-01 has been evaluated in the Phase 2b VIRAGE study in pancreatic cancer, a Phase 1 study in retinoblastoma and other Phase 1 studies in solid tumors, …

Nitish Kishor | 13 November 2026

Trio-Tech International (NASDAQ:TRT) Reports First-Quarter Fiscal 2027 Revenue Up 28.6% to USD 19.9 Million

The filing states that total revenue increased by USD 4,435 thousand, or 28.6%, to USD 19,949 thousand in the first quarter of fiscal 2027.

Nitish Kishor | 13 November 2026

Taysha Gene Therapies (NASDAQ:TSHA) Reports All 33 TSHA-102 Patients Through Acute Safety Window

Management said that, following completion of dosing in both the REVEAL pivotal and ASPIRE trials, all 33 patients dosed with TSHA-102 have cleared the acute post-dosing safety monitoring period associated with AAV gene therapies. Of these, 29 were dosed in the REVEAL Phase 1/2 …

Nitish Kishor | 13 November 2026

Twist Bioscience (NASDAQ:TWST) Posts Positive Adjusted EBITDA in Fiscal Fourth Quarter and Guides to USD 550 Million in Fiscal 2027 Revenue

DNA Synthesis and Protein Solutions revenue grew 33% to USD 61.0 million, against USD 46.0 million, and grew 8% sequentially from USD 56.6 million. NGS Applications revenue grew 24% to USD 65.7 million, against USD 53.0 million, and grew 6% sequentially from USD 61.8 …

Nitish Kishor | 13 November 2026

United States Antimony (NYSE:UAMY) Reports Third-Quarter Revenue of USD 10.1 Million With Gross Margin of 42% and New Volume Guidance

Chief Financial Officer Shawn Winkler said revenue was up 16% year over year and 28% from the second quarter, withGross Profitmore than doubling.

Nitish Kishor | 13 November 2026
Support

Hi! How can we help you today?

Loading…